Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06496256 · ClinicalTrials.gov registry record · NA
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
A NA study of Prostate Cancer, sponsored by Palette Life Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 84
- Enrollment target
- 5
- Study locations
NCT06496256: Recruiting NA study of Prostate Cancer, sponsored by Palette Life Sciences.
NCT06496256 is a NA study of Prostate Cancer that is actively recruiting participants, run by Palette Life Sciences. The registered enrollment target is 84 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (86% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06496256, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by Palette Life Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
- 5
- Study locations
Study Summary
Barrigel is intended to temporarily position the anterior rectal wall away from the prostate or prostate bed during radiotherapy treatment for prostate cancer and, in creating this space, it is the intent of Barrigel to reduce the radiation dose delivered to the anterior rectum.
Conditions Studied
Interventions
- DEVICE Barrigel
- DEVICE Transrectal Ultrasound
Study Locations (5)
Texas
- Urology Austin - Austin
- Houston Metro Urology - Houston
Massachusetts
- Dana Farber Cancer Institute - Boston
New Jersey
- Summit Health - Clifton
Victoria
- GenesisCare Ringwood - Melbourne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2024-10-31 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06496256
The ClinicalTrials.gov registry entry for NCT06496256 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (86% lower). The listed sponsor is Palette Life Sciences, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Barrigel is the first listed.
NCT06496256 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Texas, Massachusetts, New Jersey.
Frequently Asked Questions
What is clinical trial NCT06496256 about?
NCT06496256 is a clinical study titled "Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial". Barrigel is intended to temporarily position the anterior rectal wall away from the prostate or prostate bed during radiotherapy treatment for prostate cancer and, in creating this space, it is the intent of Barrigel to reduce the radiation dose delivered to the anterior rectum.
What is the current status of trial NCT06496256?
This trial is currently recruiting. It is a NA study. The enrollment target is 84 participants. The study started on 2024-10-31. Estimated completion is 2027-12-31.
What conditions does trial NCT06496256 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT06496256?
The interventions under investigation include: Barrigel (DEVICE), Transrectal Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT06496256?
This trial is sponsored by Palette Life Sciences, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06496256 being conducted?
This trial has 5 study locations across Massachusetts, New Jersey, Texas, Victoria. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.